These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29153540)

  • 1. Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.
    Chong GO; Lee YH; Han HS; Lee HJ; Park JY; Hong DG; Lee YS; Cho YL
    Gynecol Oncol; 2018 Jan; 148(1):97-102. PubMed ID: 29153540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery.
    Lai CH; Chang CJ; Huang HJ; Hsueh S; Chao A; Yang JE; Lin CT; Huang SL; Hong JH; Chou HH; Wu TI; Huang KG; Wang CC; Chang TC
    J Clin Oncol; 2007 Aug; 25(24):3628-34. PubMed ID: 17704412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
    Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
    Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of human papillomavirus genotype in cervical adeno-adenosquamous carcinoma.
    Lai CH; Chou HH; Chang CJ; Wang CC; Hsueh S; Huang YT; Chen YR; Chang HP; Chang SC; Lin CT; Chao A; Qiu JT; Huang KG; Chen TC; Jao MS; Chen MY; Liou JD; Huang CC; Chang TC; Patsner B
    Eur J Cancer; 2013 Feb; 49(3):633-41. PubMed ID: 23031554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
    Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
    Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy.
    Kim JY; Park S; Nam BH; Roh JW; Lee CH; Kim YH; Shin HJ; Lee SK; Kong SY; Seong MW; Han TJ; Lee MY; Cho KH; Park SY
    J Clin Oncol; 2009 Oct; 27(30):5088-93. PubMed ID: 19770372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent prognostic role of human papillomavirus genotype in cervical cancer.
    Hang D; Jia M; Ma H; Zhou J; Feng X; Lyu Z; Yin J; Cui H; Yin Y; Jin G; Hu Z; Shen H; Zhang K; Li N; Dai M
    BMC Infect Dis; 2017 Jun; 17(1):391. PubMed ID: 28583086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
    Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of human papillomavirus in anal squamous cell carcinoma.
    Ravenda PS; Magni E; Botteri E; Manzotti M; Barberis M; Vacirca D; Trovato CM; Dell'Acqua V; Leonardi MC; Sideri M; Fazio N; Zampino MG
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):1033-8. PubMed ID: 25209946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implication of human papillomavirus types and species in cervical cancer patients undergoing primary treatment.
    Lau YM; Cheung TH; Yeo W; Mo F; Yu MY; Lee KM; Ho WC; Yeung AC; Law PT; Chan PK
    PLoS One; 2015; 10(4):e0122557. PubMed ID: 25855986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.
    Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M
    BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV-18 is a poor prognostic factor, unlike the HPV viral load, in patients with stage IB-IIA cervical cancer undergoing radical hysterectomy.
    Kang WD; Kim CH; Cho MK; Kim JW; Cho HY; Kim YH; Choi HS; Kim SM
    Gynecol Oncol; 2011 Jun; 121(3):546-50. PubMed ID: 21334052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
    Schwartz SM; Daling JR; Shera KA; Madeleine MM; McKnight B; Galloway DA; Porter PL; McDougall JK
    J Clin Oncol; 2001 Apr; 19(7):1906-15. PubMed ID: 11283122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of treatment response in cervical carcinoma patients infected with human papillomavirus 16 and human papillomavirus 18 who are treated with chemoradiation.
    Narayanan GS; Ganesh MS; Kumar R
    J Cancer Res Ther; 2021; 17(1):204-210. PubMed ID: 33723156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P16 and HPV Genotype Significance in HPV-Associated Cervical Cancer-A Large Cohort of Two Tertiary Referral Centers.
    da Mata S; Ferreira J; Nicolás I; Esteves S; Esteves G; Lérias S; Silva F; Saco A; Cochicho D; Cunha M; Del Pino M; Ordi J; Félix A
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node human papillomavirus DNA positivity in uterine cervical cancers and its relationship with prognostic factors.
    Baser E; Can F; Unlukaplan M; Ayhan A
    Int J Gynecol Cancer; 2011 Jan; 21(1):117-22. PubMed ID: 21330836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV genotypes predict survival benefits from concurrent chemotherapy and radiation therapy in advanced squamous cell carcinoma of the cervix.
    Wang CC; Lai CH; Huang YT; Chao A; Chou HH; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e499-506. PubMed ID: 22889667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of HPV 16/18 infection on clinical outcomes in locally advanced cervical cancers treated with radical radio (chemo) therapy - A prospective observational study.
    Mahantshetty U; Teni T; Naga P; Hotwani C; Umesh S; Kannan S; Hande V; Pawar S; Engineer R; Chopra S; Deodhar K; Maheshwari A; Gurram L; Gupta S; Shrivastava SK
    Gynecol Oncol; 2018 Feb; 148(2):299-304. PubMed ID: 29203175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
    Brotherton JML; Tabrizi SN; Phillips S; Pyman J; Cornall AM; Lambie N; Anderson L; Cummings M; Payton D; Scurry JP; Newman M; Sharma R; Saville M; Garland SM
    Int J Cancer; 2017 Oct; 141(8):1576-1584. PubMed ID: 28677147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes.
    Füle T; Csapó Z; Máthé M; Tátrai P; László V; Papp Z; Kovalszky I
    Gynecol Oncol; 2006 Mar; 100(3):570-8. PubMed ID: 16325245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.